SS Innovations International (SSII) Common Equity (2016 - 2026)
SS Innovations International's (SSII) quarterly Common Equity came in at $54.5 million in Q1 2026, up 34.45% year-on-year from $40.6 million in Q1 2025, and up 42.66% quarter-over-quarter from $38.2 million in Q4 2025.
SS Innovations International (SSII) Common Equity (2016 - 2026) Analysis & Trends
SS Innovations International has disclosed Common Equity across 11 years of filings, most recently posting $54.5 million for Q1 2026.
- Common Equity for Q1 2026 came in at $54.5 million, up 34.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $54.5 million (up 34.45% YoY), and the FY2025 annual result was $38.2 million, up 184.0% from the prior year.
- Common Equity came in at $54.5 million for Q1 2026 at SS Innovations International, up from $38.2 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $54.5 million in Q1 2026 to a low of -$4.0 million in Q1 2023.
- The 5-year median for Common Equity is $14.8 million (2024), against an average of $17.7 million.
- Across the five-year window, Common Equity plunged 970.39% in 2023 and surged 1223.58% in 2024, its largest moves.
- SS Innovations International's Common Equity stood at -$2.7 million in 2022, then surged by 836.15% to $19.7 million in 2023, then sank by 31.75% to $13.5 million in 2024, then surged by 184.0% to $38.2 million in 2025, then jumped by 42.66% to $54.5 million in 2026.
- The last three Common Equity figures came in at $54.5 million (Q1 2026), $38.2 million (Q4 2025), and $39.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 52.70 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 22.98 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 48.99 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 26.10 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 2.96 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.68 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 7.20 Bn |
| 10 | SS Innovations International | 689.95 Mn | 666.34 Mn | 5.33 Mn | 54.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 54.52 Mn |
| Dec 31, 2025 | 38.22 Mn |
| Sep 30, 2025 | 39.65 Mn |
| Jun 30, 2025 | 42.02 Mn |
| Mar 31, 2025 | 40.55 Mn |
| Dec 31, 2024 | 13.46 Mn |
| Sep 30, 2024 | 13.69 Mn |
| Jun 30, 2024 | 14.77 Mn |
| Mar 31, 2024 | 16.75 Mn |
| Dec 31, 2023 | 19.72 Mn |
| Sep 30, 2023 | 16.37 Mn |
| Jun 30, 2023 | 1.12 Mn |
| Mar 31, 2023 | -4.04 Mn |
| Dec 31, 2022 | -2.68 Mn |
| Sep 30, 2022 | -1.66 Mn |
| Jun 30, 2022 | -1.15 Mn |
| Mar 31, 2022 | -377,048.00 |
| Dec 31, 2021 | 585,611.00 |
| Sep 30, 2021 | -941,496.00 |
| Jun 30, 2021 | -857,933.00 |